TWIST1 and non-small cell lung carcinoma: In another study about Non-Small Cell Lung Cancer (NSCLC), Twist1 was established as a core component of PI3K/AKT/Twist1 pathway through which the recombinant total flavonoid aglycones extract significantly inhibited the glycolytic pathway and EMT of A549 cells [57].